JP2007505904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505904A5 JP2007505904A5 JP2006526870A JP2006526870A JP2007505904A5 JP 2007505904 A5 JP2007505904 A5 JP 2007505904A5 JP 2006526870 A JP2006526870 A JP 2006526870A JP 2006526870 A JP2006526870 A JP 2006526870A JP 2007505904 A5 JP2007505904 A5 JP 2007505904A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- patient
- adipose
- enriched population
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 9
- 230000001172 regenerating effect Effects 0.000 claims 9
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 5
- 230000004048 modification Effects 0.000 claims 4
- 238000012986 modification Methods 0.000 claims 4
- 239000012530 fluid Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000037361 pathway Effects 0.000 claims 3
- 206010059245 Angiopathy Diseases 0.000 claims 2
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 2
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 230000006496 vascular abnormality Effects 0.000 claims 2
- 208000019553 vascular disease Diseases 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 230000005856 abnormality Effects 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000002870 angiogenesis inducing agent Substances 0.000 claims 1
- 230000002491 angiogenic effect Effects 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 206010003230 arteritis Diseases 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 230000002169 extracardiac Effects 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000008736 traumatic injury Effects 0.000 claims 1
- 230000006444 vascular growth Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50358903P | 2003-09-17 | 2003-09-17 | |
| US60/503,589 | 2003-09-17 | ||
| PCT/US2004/021480 WO2005034843A2 (en) | 2003-09-17 | 2004-07-01 | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007505904A JP2007505904A (ja) | 2007-03-15 |
| JP2007505904A5 true JP2007505904A5 (enExample) | 2007-08-16 |
| JP5019511B2 JP5019511B2 (ja) | 2012-09-05 |
Family
ID=34434859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526870A Expired - Fee Related JP5019511B2 (ja) | 2003-09-17 | 2004-07-01 | 抹消血管疾患およびそれに関連する障害の治療において新生細胞を利用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2348103B1 (enExample) |
| JP (1) | JP5019511B2 (enExample) |
| CN (1) | CN1878470A (enExample) |
| AU (1) | AU2004280149A1 (enExample) |
| BR (1) | BRPI0414455A (enExample) |
| CA (1) | CA2539346A1 (enExample) |
| DK (2) | DK2348103T3 (enExample) |
| ES (1) | ES2633604T3 (enExample) |
| MX (1) | MXPA06003088A (enExample) |
| SG (1) | SG146666A1 (enExample) |
| WO (1) | WO2005034843A2 (enExample) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
| US7514075B2 (en) | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
| US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
| KR101083454B1 (ko) | 2001-12-07 | 2011-11-16 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법 |
| US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| US7595043B2 (en) | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
| US20030205538A1 (en) | 2002-05-03 | 2003-11-06 | Randel Dorian | Methods and apparatus for isolating platelets from blood |
| US7832566B2 (en) | 2002-05-24 | 2010-11-16 | Biomet Biologics, Llc | Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles |
| US7992725B2 (en) | 2002-05-03 | 2011-08-09 | Biomet Biologics, Llc | Buoy suspension fractionation system |
| US20060278588A1 (en) | 2002-05-24 | 2006-12-14 | Woodell-May Jennifer E | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7845499B2 (en) | 2002-05-24 | 2010-12-07 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| WO2003099412A1 (en) | 2002-05-24 | 2003-12-04 | Biomet Manufacturing Corp. | Apparatus and method for separating and concentrating fluids containing multiple components |
| JP4731556B2 (ja) * | 2004-07-02 | 2011-07-27 | サイトリ セラピューティクス インコーポレイテッド | 臨床的に安全な脂肪組織由来再生細胞を単離し、使用するためのシステムおよび方法 |
| EP2666494B1 (en) * | 2005-02-07 | 2018-01-17 | Hanuman LLC | Platelet rich plasma concentrate apparatus and method |
| US7708152B2 (en) | 2005-02-07 | 2010-05-04 | Hanuman Llc | Method and apparatus for preparing platelet rich plasma and concentrates thereof |
| US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US8062286B2 (en) | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
| US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
| DK1885382T3 (da) * | 2005-05-25 | 2011-06-20 | Cytori Therapeutics Inc | Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af cardiovaskulære tilstande |
| AU2013216683B2 (en) * | 2005-05-25 | 2016-06-23 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US8567609B2 (en) | 2006-05-25 | 2013-10-29 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8034014B2 (en) | 2007-03-06 | 2011-10-11 | Biomet Biologics, Llc | Angiogenesis initation and growth |
| US7806276B2 (en) * | 2007-04-12 | 2010-10-05 | Hanuman, Llc | Buoy suspension fractionation system |
| US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
| KR20080103637A (ko) * | 2007-05-25 | 2008-11-28 | 주식회사 알앤엘바이오 | 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물 |
| JP5196890B2 (ja) * | 2007-06-29 | 2013-05-15 | オリンパス株式会社 | 有核細胞回収装置および有核細胞の回収方法 |
| RU2010109698A (ru) * | 2007-09-19 | 2011-09-27 | Плуристем Лтд. (Il) | Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях |
| PL2259774T3 (pl) | 2008-02-27 | 2013-04-30 | Biomet Biologics Llc | Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1 |
| US8337711B2 (en) | 2008-02-29 | 2012-12-25 | Biomet Biologics, Llc | System and process for separating a material |
| US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
| WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
| US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| ES2625893T3 (es) | 2009-05-01 | 2017-07-20 | Bimini Technologies Llc | Sistemas, procedimientos y composiciones para optimizar injertos enriquecidos con tejido y células |
| JP5431786B2 (ja) * | 2009-05-12 | 2014-03-05 | 國立中央大學 | 造血幹細胞を単離、生体外（ｅｘｖｉｖｏ）増殖および回収するためのシステムおよび方法 |
| US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
| US8591391B2 (en) | 2010-04-12 | 2013-11-26 | Biomet Biologics, Llc | Method and apparatus for separating a material |
| US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
| JP5628131B2 (ja) * | 2011-10-19 | 2014-11-19 | サイトリ セラピューティクス インコーポレイテッド | 心血管状態の治療において脂肪組織由来細胞を使用する方法 |
| US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
| AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
| US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
| WO2015149098A1 (de) | 2014-03-31 | 2015-10-08 | Liporegena Gmbh | Vorrichtung zur entnahme und portionierung von fettgewebe |
| US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
| US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| WO2017024182A1 (en) | 2015-08-04 | 2017-02-09 | Duke University | Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
| WO2017141831A1 (ja) * | 2016-02-16 | 2017-08-24 | ロート製薬株式会社 | 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法 |
| US11467156B2 (en) | 2016-06-01 | 2022-10-11 | Duke University | Nonfouling biosensors |
| KR102579835B1 (ko) | 2016-06-08 | 2023-09-15 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 조직 및 세포를 프로세싱하기 위한 방법 및 장치 |
| JP2020500150A (ja) | 2016-09-23 | 2020-01-09 | デューク ユニバーシティ | 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド |
| WO2018132732A1 (en) | 2017-01-12 | 2018-07-19 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| WO2019006374A1 (en) | 2017-06-30 | 2019-01-03 | Duke University | ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS |
| WO2019054468A1 (ja) * | 2017-09-15 | 2019-03-21 | 株式会社カネカ | 細胞含有試料からの細胞の遊離方法 |
| WO2019147954A1 (en) | 2018-01-26 | 2019-08-01 | Duke University | Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same |
| US12257308B2 (en) | 2018-04-30 | 2025-03-25 | Duke University | Stimuli-responsive PEG-like polymer-based drug delivery platform |
| US11649275B2 (en) | 2018-08-02 | 2023-05-16 | Duke University | Dual agonist fusion proteins |
| CN113260336A (zh) * | 2018-10-25 | 2021-08-13 | 恩朵罗杰克斯有限责任公司 | 分叉支架移植物、支架和方法 |
| US20210395691A1 (en) * | 2018-11-09 | 2021-12-23 | Figene, Llc | Means and methods of preventing or reversing aging |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| WO2021247952A2 (en) * | 2020-06-05 | 2021-12-09 | Duke University | Compositions and methods for augmenting autologous fat grafts |
| AU2023415952A1 (en) | 2022-12-27 | 2025-07-24 | AVITA Medical Americas, LLC | System for automated preparation of a regenerative epidermal suspension and related methods of use |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470307A (en) * | 1994-03-16 | 1995-11-28 | Lindall; Arnold W. | Catheter system for controllably releasing a therapeutic agent at a remote tissue site |
| US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
| FR2742662B1 (fr) | 1995-12-21 | 1998-01-23 | Centre Nat Rech Scient | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments |
| US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
| US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
| US5980887A (en) * | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
| US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
| ATE286692T1 (de) | 1998-04-07 | 2005-01-15 | Macropore Inc | Membran mit gewellter oberfläche zur führung des gewebes |
| US6001642A (en) | 1998-06-29 | 1999-12-14 | Wyle Laboratories, Inc. Life Sciences | Bioreactor and cell culturing processes using the bioreactor |
| IL145002A0 (en) * | 1999-03-10 | 2002-06-30 | Univ Pittsburgh | Adipose-derived stem cells and lattices |
| US6653146B1 (en) | 1999-11-15 | 2003-11-25 | Chemclean Corporation | Bio-burden visualization system |
| MXPA02008897A (es) | 2000-03-10 | 2004-10-14 | Macropore Inc | Micro-membranas barrera reabsorbibles para atenuacion de tejido de cicatriz durante sanado. |
| US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
| US6635064B2 (en) | 2000-10-04 | 2003-10-21 | Macropore Biosurgery, Inc. | Non-scatterable, radio-opaque material for medical imaging applications |
| US6890728B2 (en) * | 2001-04-09 | 2005-05-10 | Medtronic, Inc. | Methods of isolating blood components using a microcentrifuge and uses thereof |
| US20030054331A1 (en) * | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
| KR101083454B1 (ko) * | 2001-12-07 | 2011-11-16 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법 |
| US20050250202A1 (en) * | 2002-03-19 | 2005-11-10 | March Keith L | Adipose stromal stem cells for tissue and vascular modification |
| ES2560847T3 (es) * | 2002-07-31 | 2016-02-23 | Yves Saint-Laurent Parfums | Células madre procedentes de tejido adiposo y células diferenciadas procedentes de estas células |
| ATE524070T1 (de) * | 2003-02-20 | 2011-09-15 | Cytori Therapeutics Inc | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden |
-
2004
- 2004-07-01 DK DK10183850.6T patent/DK2348103T3/da active
- 2004-07-01 DK DK04756641.9T patent/DK1670315T3/en active
- 2004-07-01 WO PCT/US2004/021480 patent/WO2005034843A2/en not_active Ceased
- 2004-07-01 CN CNA2004800333682A patent/CN1878470A/zh active Pending
- 2004-07-01 AU AU2004280149A patent/AU2004280149A1/en not_active Abandoned
- 2004-07-01 BR BRPI0414455-4A patent/BRPI0414455A/pt not_active IP Right Cessation
- 2004-07-01 JP JP2006526870A patent/JP5019511B2/ja not_active Expired - Fee Related
- 2004-07-01 ES ES04756641.9T patent/ES2633604T3/es not_active Expired - Lifetime
- 2004-07-01 CA CA002539346A patent/CA2539346A1/en not_active Abandoned
- 2004-07-01 EP EP10183850.6A patent/EP2348103B1/en not_active Expired - Lifetime
- 2004-07-01 EP EP04756641.9A patent/EP1670315B1/en not_active Expired - Lifetime
- 2004-07-01 MX MXPA06003088A patent/MXPA06003088A/es not_active Application Discontinuation
- 2004-07-01 SG SG200806960-1A patent/SG146666A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007505904A5 (enExample) | ||
| Tomita et al. | Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation | |
| Flanagan et al. | The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning | |
| Scarritt et al. | A review of cellularization strategies for tissue engineering of whole organs | |
| Sakakibara et al. | Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation | |
| Li et al. | Cardiomyocyte transplantation improves heart function | |
| Arora et al. | Banking stem cells from human exfoliated deciduous teeth (SHED): saving for the future | |
| Bijonowski et al. | Bioreactor design for perfusion-based, highly vascularized organ regeneration | |
| EP3878404A2 (en) | Artificial vascular graft | |
| JP2012139541A (ja) | 三次元組織構造体 | |
| Xu et al. | Generation of ring-shaped human iPSC-derived functional heart microtissues in a Möbius strip configuration | |
| Vaegler et al. | Tissue engineering in urothelium regeneration | |
| JP2005229906A (ja) | 細胞播種基材の保管方法 | |
| JP2012516853A (ja) | 分化した内皮前駆細胞の治療的使用 | |
| JP4061149B2 (ja) | 細胞培養装置および細胞培養方法 | |
| Wei et al. | Heparin-conjugated injectable hydrogels with sustained releasing capability for promotion of H-type vessels formation and rat femoral bone defects repair | |
| Ohno et al. | Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function | |
| Gill et al. | Future perspectives in bladder tissue engineering | |
| Okhovatian et al. | Biofabrication strategies for cardiac tissue engineering | |
| CN116392463B (zh) | 乳酸盐在用于制备促血管生成的药物中的用途 | |
| RU2299073C1 (ru) | Биотрансплантат и способ лечения хронической сердечной недостаточности (варианты) | |
| CN111304150A (zh) | 可促进移植物微循环血供恢复的ADSCs与EPCs干细胞体系 | |
| Azhar et al. | Bioengineered cardiac patch scaffolds | |
| CN106834119A (zh) | 轴型血管化组织瓣培育器 | |
| Malchesky | Artificial organs 2014: a year in review |